dc.contributor.author |
Poso, Antti |
|
dc.date.accessioned |
2020-08-31T07:06:28Z |
|
dc.date.available |
2020-08-31T07:06:28Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
1879-0720 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/105890 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ejps.2020.105321 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20200715072417_00152 |
|
utue.personen.roh |
Singha, Prosanta K. |
|
utue.personen.roh |
Maklin, Kiira |
|
utue.personen.roh |
Vihavainen, Taina |
|
utue.personen.roh |
Laitinen, Tuomo |
|
utue.personen.roh |
Nevalainen, Tapio J. |
|
utue.personen.roh |
Patil, Mahadeo R. |
|
utue.personen.roh |
Tonduru, Arun K. |
|
utue.personen.roh |
Poso, Antti |
|
utue.personen.roh |
Laitinen, Jarmo T. |
|
utue.personen.roh |
Savinainen, Juha R. |
|
dcterms.isPartOf.ZSTitelID |
European Journal of Pharmaceutical Sciences |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 105321 |
de_DE |
dcterms.isPartOf.ZS-Volume |
149 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |